Skip to main content
Noile-Immune Biotech Inc. logo

Noile-Immune Biotech Inc. — Investor Relations & Filings

Ticker · 4893 ISIN · JP3759560000 T Manufacturing
Open in API
Filings indexed 27 across all filing types
Latest filing 2024-05-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 4893

About Noile-Immune Biotech Inc.

https://www.noile-immune.com/en.html

Noile-Immune Biotech Inc. is a clinical-stage biotechnology company focused on the development and commercialization of novel cancer immunotherapies. The company specializes in next-generation Chimeric Antigen Receptor T-cell (CAR-T) therapies, leveraging its proprietary PRIME (Proliferation-Inducing and Migration-Enhancing) technology. This platform is designed to enhance the efficacy of CAR-T cells by enabling them to produce specific cytokines and chemokines, thereby improving their proliferation, persistence, and ability to infiltrate the tumor microenvironment. A primary goal is to develop effective treatments for solid tumors, a significant challenge for conventional cell therapies. The company advances its pipeline through internal research and development as well as strategic partnerships.

Recent filings

Filing Released Lang Actions
四半期報告書－第10期第1四半期(2024/01/01－2024/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, covering the first quarter of the 10th fiscal year (January 1, 2024, to March 31, 2024). It contains detailed financial statements, including the balance sheet and income statement, and management analysis. This fits the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-14 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report) and explicitly states in Section 1 that it is being filed pursuant to the Financial Instruments and Exchange Act following the resolution of matters at the Annual General Meeting (AGM) held on March 27, 2024. Section 2 details the resolutions passed, specifically the election of five directors, along with the vote counts (approval, dissent, abstention) and the required majority threshold. This content perfectly matches the definition of reporting the results of a shareholder vote, which corresponds to the Declaration of Voting Results & Voting Rights Announcements (DVA). Although it relates to an AGM, the focus is on the *results* of the vote, not the presentation materials (AGM-R) or the proxy solicitation (DEF 14A/PSI).
2024-04-02 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS) rather than the report itself. FY 2023
2024-03-29 Japanese
内部統制報告書－第9期(2023/01/01－2023/12/31)
Governance Information Classification · 100% confidence The document is explicitly titled "内部統制報告書" (Internal Control Report) in the header and within the filing details. It references the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法第24条の４の４第１項), which mandates the filing of an Internal Control Report in Japan. The content discusses the framework, scope, criteria, and conclusion regarding the effectiveness of internal controls over financial reporting as of the fiscal year-end (2023年12月31日). This directly corresponds to the requirements for an Audit Report/Information filing, specifically concerning internal controls, which aligns best with the 'Audit Report / Information (AR)' category, as it is a formal report on internal control effectiveness, distinct from a full Annual Report (10-K) or a simple Earnings Release (ER).
2024-03-29 Japanese
有価証券報告書－第9期(2023/01/01－2023/12/31)
Annual Report Classification · 100% confidence The document is a 'Yuka Shoken Hokokusho' (Annual Securities Report) filed with the Kanto Local Finance Bureau in Japan. It covers the fiscal year from January 1, 2023, to December 31, 2023. This document is the Japanese equivalent of a 10-K, containing comprehensive financial statements, business descriptions, and management analysis. Therefore, it is classified as a 10-K. FY 2023
2024-03-29 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-8 of the Financial Instruments and Exchange Act of Japan, which accompanies a Quarterly Report (Dai-san shihanki hokokusho). Since this document is a formal regulatory filing confirming the accuracy of the quarterly report and is submitted to the Kanto Local Finance Bureau, it falls under the category of Regulatory Filings (RNS) as it is a specific legal compliance document rather than the quarterly report itself or a simple announcement.
2023-11-13 Japanese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.